Drug Farm Announces FDA Fast Track Designation for First-in-Class ALPK1 Inhibitor DF-003 for the Treatment of ROSAH Syndrome Drug Farm, a clinical-stage biopharmaceutical company advancing two novel ...

Lionel Messi’s recent visit to India turned heads not only for its cultural and humanitarian significance but also for an extraordinary luxury moment that quickly became the talking point of the trip, ...

China’s Fujian carrier has successfully developed electromagnetic catapults—leapfrogging the US Navy, which mostly uses steam-powered catapults and has struggled to implement electromagnetic ones. The ...

CG Oncology recently reported promising developments from the BOND-003 trial with their investigational therapy, cretostimogene, showing significant efficacy in non-muscle invasive bladder cancer ...

China’s Type 003 aircraft carrier, Fujian, represents a leap in naval power and places it alongside the world’s largest carriers. Comparable in size to the U.S. Navy’s USS Gerald R. Ford, the Fujian ...

The electromagnetic catapults will significantly enhance the capabilities of the Type 003 Fujian, allowing for heavier aircraft to operate from its flight deck. The sea trials of the People’s ...

Text messages regarding "State Code 15c-16.003" are fake and designed to steal personal information. Illinois Secretary of State Alexi Giannoulias warned residents in a May 27 press release about the ...

The Fujian, China’s most advanced aircraft carrier, is expected to be commissioned by the end of the year, according to state broadcaster CCTV. In a feature broadcast on Tuesday, the third anniversary ...

The Georgia Department of Driver Services (DDS) has alerted drivers about a new scam text circulating the state. The fraudulent message claims to be from the "Georgia State Department of Motor ...

A phase II study of ACR-368 and low dose gemcitabine combination therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma. This is an ASCO Meeting Abstract from the ...

Positive results show that a single dose of BPL-003, administered adjunctively to SSRIs, produced a rapid and long-lasting antidepressant effect for up to three months after dosing. BPL-003 was ...